SLN NASDAQ
Silence Therapeutics plc
1W: -4.8%
1M: -28.1%
3M: +0.6%
YTD: +73.0%
1Y: +108.6%
3Y: +9.7%
5Y: -51.2%
$10.64
-0.07 (-0.65%)
Weekly Expected Move ±5.2%
$10
$10
$11
$11
$12
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$131M
-51.9% ▼
5Y CAGR: +8.9%
Total Liabilities
$51M
-25.2% ▼
5Y CAGR: -7.8%
Shareholders Equity
$46M
-65.5% ▼
5Y CAGR: +38.5%
Cash & Investments
$85M
-42.2% ▼
5Y CAGR: +17.8%
Total Debt
-$160K
-236.8% ▼
Net Debt
-$11M
+90.6% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $74M | $55M | $69M | $121M | $11M |
| Short-Term Investments | $0 | $16M | $0 | $26M | $74M |
| Cash & ST Investments | $74M | $71M | $69M | $147M | $85M |
| Net Receivables | $331K | $915K | $24M | $27M | $18M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $8M | $16M | $0 | $0 | $6M |
| Total Current Assets | $86M | $97M | $103M | $187M | $119M |
| Property, Plant & Equip. | $2M | $2M | $2M | $2M | $2M |
| Goodwill & Intangibles | $8M | $8M | $10M | $10M | $11M |
| Long-Term Investments | $301K | $284K | $0 | $0 | $0 |
| Other Non-Current Assets | $0 | $0 | $4M | $4M | $127K |
| Total Non-Current Assets | $10M | $11M | $16M | $15M | $13M |
| Total Assets | $96M | $108M | $119M | $203M | $131M |
| — Liabilities — | |||||
| Accounts Payable | $4M | $3M | $3M | $4M | $3M |
| Short-Term Debt | $0 | $0 | $228K | $0 | -$89K |
| Deferred Revenue | $0 | $0 | $7M | $306K | $0 |
| Other Current Liabilities | $4M | $9M | $9M | $3M | $10M |
| Total Current Liabilities | $15M | $22M | $22M | $17M | $14M |
| Long-Term Debt | $0 | $0 | $0 | $0 | -$71K |
| Other Non-Current Liab. | $73M | $63M | $0 | $0 | $0 |
| Total Non-Current Liabilities | $73M | $63M | $75M | $52M | -$71K |
| Total Liabilities | $88M | $85M | $97M | $69M | $51M |
| — Equity — | |||||
| Common Stock | $4M | $5M | $9M | $10M | $8M |
| Retained Earnings | -$223M | -$263M | -$432M | -$474M | -$418M |
| Accumulated OCI | $43M | $53M | $40M | -$12M | -$2M |
| Total Stockholders Equity | $9M | $22M | $22M | $134M | $46M |
| Total Liabilities & Equity | $96M | $108M | $119M | $203M | $98M |
| — Key Metrics — | |||||
| Total Debt | $137K | $446K | $346K | $117K | -$160K |
| Net Debt | -$73M | -$54M | -$68M | -$121M | -$11M |
| Total Investments | $301K | $17M | $0 | $26M | $74M |